Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors

Clinical trial NCT00227773 · WITHDRAWN

Trial details

NCT number: NCT00227773
Sponsor: Eastern Cooperative Oncology Group
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Carcinoid Tumor Islet Cell Carcinoma

Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.